The Anti-AGEing and RAGEing Potential of Isothiocyanates

Area of Science:

• Nutritional Biochemistry
• Phytochemistry
• Molecular Biology

Background:

• Isothiocyanates (ITCs) are organo-sulfur compounds derived from glucosinolates in cruciferous vegetables.
• Advanced glycation end products (AGEs) accumulate with age and lifestyle factors, promoting oxidative and inflammatory stress.
• AGEs contribute to chronic disease pathogenesis via receptor for AGE (RAGE) activation.

Purpose of the Study:

• To review the evidence on ITCs' antioxidant and anti-inflammatory potential.
• To explore how ITCs may mitigate the detrimental effects of AGEs.
• To discuss molecular mechanisms underlying ITC-mediated inhibition of AGEs and RAGE signaling.

Main Methods:

• Comprehensive literature review of in vivo and in vitro studies on ITCs and AGEs.
• Analysis of molecular pathways involved in ITC-RAGE-AGE interactions.
• Synthesis of evidence regarding the therapeutic potential of ITCs in chronic disease.

Main Results:

• ITCs possess intrinsic antioxidant and anti-inflammatory properties.
• ITC administration may temper the pathogenic effects of AGEs by inhibiting AGE bioavailability.
• ITCs may reduce RAGE-mediated pro-oxidant and pro-inflammatory signaling.

Conclusions:

• ITCs show promise in counteracting AGE-induced pathologies.
• Understanding ITC's molecular impact on AGE biogenesis could lead to novel interventions.
• Targeting ITC pathways may offer strategies to prevent or reverse chronic disease risk associated with lifestyle factors.